Infusion Consumables was the largest of Icu Medical Inc/De’s 3 reported lines in fiscal 2025, at $1.11B — 50% of $2.23B.
| Product and Service | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infusion Consumables | $974.99M | $969.13M | $1.04B | $1.11B | ||||||||||||
| Vital Care | $687.57M | $660.95M | $690.77M | $437.92M | ||||||||||||
| Infusion Systems | $617.44M | $629.04M | $652.41M | $684.21M | ||||||||||||
| Iv Solutions | — | — | — | — | ||||||||||||
| Infusion Therapy | — | — | — | — | ||||||||||||
| Infusion Therapy Revenue | — | — | — | — | ||||||||||||
| Critical Care Revenue | — | — | — | — | ||||||||||||
| Critical Care | — | — | — | — | ||||||||||||
| Oncology Revenue | — | — | — | — | ||||||||||||
| Other Revenue | — | — | — | — | ||||||||||||
| Total | $2.28B | $2.26B | $2.38B | $2.23B |
In fiscal 2025, which ended December 31, 2025, the 3 revenue lines Icu Medical Inc/De reported in this breakdown added up to $2.23B. That was down 6.3% from $2.38B in fiscal 2024. Infusion Consumables was the largest revenue line, at $1.11B or 49.7% of the total, followed by Infusion Systems ($684.21M, 30.7%) and Vital Care ($437.92M, 19.6%). Together, the two largest revenue lines made up 80.4% of this total.
Compared with fiscal 2024, Infusion Consumables grew the fastest, rising 6.8% to $1.11B. Vital Care fell the most, down 36.6% to $437.92M. Over fiscal 2022 to 2025, revenue across these revenue lines went from $2.28B to $2.23B, a compound annual decline of 0.7%. Infusion Consumables' share of the total rose from 42.8% to 49.7% over the same years.
The table also keeps 7 revenue lines that Icu Medical Inc/De no longer reports, so earlier years can still be read on their original basis; use "Show 7 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2010 to 2025, as reported in Icu Medical Inc/De's annual filings.
United States was the largest of Icu Medical Inc/De’s 4 reported lines in fiscal 2025, at $1.36B — 61% of $2.23B.
| Geography | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.46B | $1.44B | $1.53B | $1.36B | |||||||
| Emea | $367.41M | $373.57M | $393.53M | $411.68M | |||||||
| Apac [Domain] | $257.21M | $241.70M | $232.82M | $232.90M | |||||||
| Other Foreign Countries | $195.31M | $203.84M | $223.59M | $230.56M | |||||||
| Europe | — | — | — | — | |||||||
| Other Latam | — | — | — | — | |||||||
| Canada | — | — | — | — | |||||||
| Asia Pacific | — | — | — | — | |||||||
| Total | $2.28B | $2.26B | $2.38B | $2.23B |
In fiscal 2025, which ended December 31, 2025, the 4 regions Icu Medical Inc/De reported in this breakdown added up to $2.23B. That was down 6.3% from $2.38B in fiscal 2024. United States was the largest region, at $1.36B or 60.8% of the total, followed by Emea ($411.68M, 18.5%) and Apac [Domain] ($232.90M, 10.4%). Together, the two largest regions made up 79.2% of this total.
Compared with fiscal 2024, Emea grew the fastest, rising 4.6% to $411.68M. United States fell the most, down 11.5% to $1.36B. Over fiscal 2022 to 2025, revenue across these regions went from $2.28B to $2.23B, a compound annual decline of 0.7%. United States' share of the total fell from 64.0% to 60.8% over the same years.
The table also keeps 4 regions that Icu Medical Inc/De no longer reports, so earlier years can still be read on their original basis; use "Show 4 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2015 to 2025, as reported in Icu Medical Inc/De's annual filings.
Icu Medical Inc/De (ICUI) breaks its revenue down by revenue line and region. In fiscal 2025, its largest revenue line was Infusion Consumables, with $1.11B or 49.7% of the total, followed by Infusion Systems at $684.21M (30.7%).
Infusion Consumables was Icu Medical Inc/De's largest revenue line in fiscal 2025, with $1.11B in revenue, 49.7% of the $2.23B reported across its 3 revenue lines.
United States was Icu Medical Inc/De's largest region in fiscal 2025, with $1.36B in revenue, 60.8% of the $2.23B reported across its 4 regions.
Of the Icu Medical Inc/De revenue lines reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Infusion Consumables grew the fastest, rising 6.8% from $1.04B to $1.11B.
Every figure is taken from Icu Medical Inc/De's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by revenue line covers fiscal 2010 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.